{
  "meta": {
    "title": "Local_Anaesthetics_And_Skeletal_Muscle_Relaxants",
    "url": "https://brainandscalpel.vercel.app/local-anaesthetics-and-skeletal-muscle-relaxants-f36f1e70.html",
    "scrapedAt": "2025-11-29T18:33:29.899Z"
  },
  "questions": [
    {
      "id": 16889,
      "choices": [
        {
          "id": 67516,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sodium Thiopentone</span></span></span></p>"
        },
        {
          "id": 67517,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fentanyl</span></span></span></p>"
        },
        {
          "id": 67518,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketamine</span></span></span></p>"
        },
        {
          "id": 67519,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Halothane</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with a ruptured spleen is taken for a laparotomy. His blood pressure is 80/50 and heart rate is 125/min. Induction agent of choice for this patient is?</span></span></span></p>",
      "unique_key": "Q3915968",
      "question_audio": null,
      "question_video": null,
      "map_id": 36253,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Ketamine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ketamine </strong>is the <strong>most suitable induction agent </strong>for a patient experiencing <strong>hypotension, </strong>such as the scenario described. Ketamine uniquely <strong>supports blood pressure due to its sympathetic mimetic effects</strong>, unlike other anesthetics that might depress cardiovascular function. It acts by<strong> blocking NMDA receptors</strong>, leading to<strong> dissociative anesthesia </strong>while simultaneously <strong>preserving or even stimulating cardiovascular function. </strong>This makes it particularly valuable in patients with<strong> hypotension, </strong>ensuring <strong>cardiovascular stability </strong>during<strong> induction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Sodium Thiopentone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This agent typically results in <strong>reduced blood pressure </strong>by depressing <strong>central sympathetic tone</strong>, which could be<strong> detrimental for a hypotensive patient, </strong>risking further <strong>cardiovascular compromise.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Fentanyl:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A<strong> potent opioid</strong> that can lead to <strong>further depression of the central nervous system </strong>and potentially <strong>exacerbate hypotension </strong>and <strong>reduce heart rate</strong>, not ideal under the patient&#39;s current circulatory stress.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Halothane:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Known to <strong>decrease myocardial contractility and </strong>potentially worsen<strong> hypotension</strong>, Halothane<strong> would not </strong>be appropriate for someone whose <strong>blood pressure is already critically low</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketamine </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">uniquely preserves and can</span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> elevate blood pressure </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">during </span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">induction of anesthesia, </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">making it an </span><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">optimal choice for patients presenting with hypotension.</span></strong></span></span></p>",
      "correct_choice_id": 67518,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16883,
      "choices": [
        {
          "id": 67492,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Physostigmine</span></span></span></p>"
        },
        {
          "id": 67493,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neostigmine</span></span></span></p>"
        },
        {
          "id": 67494,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Succinylcholine</span></span></span></p>"
        },
        {
          "id": 67495,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbachol</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A perioperative patient was given a skeletal muscle relaxant that acts by competitive inhibition of nicotinic ACh receptors. What agent can be used for the reversal of its effects?</span></span></span>​​​</p>",
      "unique_key": "Q2246183",
      "question_audio": null,
      "question_video": null,
      "map_id": 36249,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Neostigmine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>skeletal muscle relaxant </strong>described is likely a <strong>non-depolarizing neuromuscular blocker (NMB) </strong>such as<strong> atracurium, vecuronium, or rocuronium. </strong>These agents <strong>competitively inhibit nicotinic acetylcholine (ACh) receptors at the neuromuscular junction</strong>. <strong>Neostigmine</strong>, a <strong>cholinesterase inhibitor</strong>, is used to <strong>reverse the effects </strong>of these muscle relaxants by increasing the <strong>concentration of acetylcholine in the neuromuscular junction</strong>, effectively overcoming the<strong> blockade created by the NMB</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Physostigmine:</strong> Also a<strong> cholinesterase inhibitor </strong>but primarily crosses the <strong>blood-brain barrier </strong>and could cause<strong> CNS adverse effects</strong>; not typically used for reversing NMBs.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Succinylcholine:</strong> A <strong>depolarizing NMB, </strong>which is <strong>inappropriate </strong>for reversal and instead causes <strong>muscle relaxation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carbachol:</strong> A <strong>cholinergic agonist </strong>used to treat <strong>glaucoma and urinary retention </strong>but<strong> not </strong>for reversing<strong> neuromuscular blockade</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understand the use of<strong> neostigmine as a reversal agent for non-depolarizing neuromuscular blockers </strong>by its mechanism of <strong>increasing acetylcholine concentration</strong>, which<strong> competes </strong>with the <strong>blocker at the nicotinic receptors.</strong></span></span></p>",
      "correct_choice_id": 67493,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16899,
      "choices": [
        {
          "id": 67556,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase risk of convulsions</span></span></span>​​​​​​</p>"
        },
        {
          "id": 67557,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase the duration of action of the local anesthetic</span></span></span></p>"
        },
        {
          "id": 67558,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both a &amp; b</span></span></span></p>"
        },
        {
          "id": 67559,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of these</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epinephrine added to a solution of lignocaine for a peripheral nerve block will:</span></span></span></p>",
      "unique_key": "Q4713552",
      "question_audio": null,
      "question_video": null,
      "map_id": 36246,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Increase the duration of action of the local anesthetic</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Epinephrine, </strong>when added to <strong>local anesthetic solutions </strong>like<strong> lignocaine, acts as a vasoconstrictor, decreasing blood flow </strong>at the site of <strong>injection</strong>. This<strong> reduces </strong>the <strong>rate of absorption of the anesthetic</strong> into the <strong>bloodstream, </strong>prolonging its <strong>local action </strong>and <strong>extending </strong>the duration of <strong>anesthesia</strong>. This is <strong>particularly useful in surgical settings </strong>to provide<strong> longer-lasting numbness</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Increase risk of convulsions:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect</strong>, as epinephrine <strong>does not </strong>typically <strong>increase the risk of convulsions </strong>related to local anesthetic use. Instead, by <strong>reducing systemic absorption</strong>, it might actually help <strong>prevent peak plasma levels </strong>that could lead to <strong>toxicity</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Both A &amp; B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect</strong>, since <strong>only B is true</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. None of these:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect, </strong>as epinephrine does<strong> increase the duration of action</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Adding epinephrine </strong>to <strong>lignocaine not only </strong>enhances the <strong>duration of the anesthetic effect </strong>but also helps<strong> minimize bleeding, </strong>making it <strong>highly beneficial </strong>for longer <strong>procedures and areas of significant vascularization</strong>.</span></span></p>",
      "correct_choice_id": 67557,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16892,
      "choices": [
        {
          "id": 67528,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atracurium</span></span></span></p>"
        },
        {
          "id": 67529,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pancuronium</span></span></span></p>"
        },
        {
          "id": 67530,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mivacurium</span></span></span></p>"
        },
        {
          "id": 67531,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vecuronium</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs undergoes Hoffman&rsquo;s elimination?</span></span></span></p>",
      "unique_key": "Q3115148",
      "question_audio": null,
      "question_video": null,
      "map_id": 36255,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Atracurium </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hoffman&rsquo;s elimination </strong>is a unique process of spontaneous<strong> non-enzymatic breakdown </strong>that occurs<strong> at physiological pH </strong>and <strong>temperature, </strong>particularly relevant for <strong>drugs </strong>used in patients with compromised<strong> liver or kidney </strong>function where<strong> drug metabolism </strong>may be<strong> impaired</strong>.<strong> Atracurium</strong>, along with its <strong>isomer Cis-atracurium</strong>, undergoes this type of elimination, making them preferable in patients with<strong> hepatic or renal insufficiency </strong>because their<strong> breakdown does not rely on organ function.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atracurium </strong>is also <strong>metabolized </strong>to produce<strong> laudanosine </strong>that is responsible for <strong>seizures. Cis-atracurium </strong>is relatively<strong> safe </strong>in this regard.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Pancuronium:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Does not undergo Hoffman&#39;s elimination</strong>; it is <strong>metabolized by the liver </strong>and <strong>excreted by the kidneys</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Mivacurium:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is<strong> metabolized by plasma cholinesterases</strong>, not through Hoffman&rsquo;s elimination.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Vecuronium:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is <strong>primarily metabolized </strong>in the<strong> liver </strong>and <strong>excreted by the kidneys,</strong> not involving Hoffman&#39;s elimination.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remember that<strong> Atracurium undergoes Hoffman&rsquo;s elimination</strong>, a process allowing <strong>safe use in patients with liver and kidney dysfunction</strong>, <strong>distinguishing it </strong>from other <strong>neuromuscular blockers </strong>that require <strong>metabolic clearance by these organs</strong>.</span></span></p>",
      "correct_choice_id": 67528,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16898,
      "choices": [
        {
          "id": 67552,
          "text": "<p><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Benzocaine</span></span></p>"
        },
        {
          "id": 67553,
          "text": "<p><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chloroprocaine</span></span></p>"
        },
        {
          "id": 67554,
          "text": "<p><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cocaine</span></span></p>"
        },
        {
          "id": 67555,
          "text": "<p><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mepivacaine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 48-year-old woman goes to her dermatologist to have a mole removed. The patient tells her physician that she had an allergic reaction to a local anesthetic the last time she had dental work performed. Examination of her dental records by her dentist reveals that the patient received procaine for a tooth extraction. Which of the following drugs would be appropriate for the present procedure?</span></span></span></p>",
      "unique_key": "Q5054333",
      "question_audio": null,
      "question_video": null,
      "map_id": 36245,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Mepivacaine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s <strong>previous allergic reaction to procaine</strong>, an<strong> ester-type </strong>local anesthetic, suggests a <strong>sensitivity to ester local anesthetics, </strong>which share <strong>common metabolic pathways </strong>and <strong>allergenic potential.</strong> Mepivacaine, an <strong>amide</strong>-type<strong> local anesthetic</strong>, is <strong>structurally and metabolically </strong>distinct from <strong>ester local anesthetics, </strong>making it a <strong>safer alternative for patients with ester allergies.</strong> It is <strong>metabolized primarily </strong>in the<strong> liver</strong>, <strong>reducing </strong>the risk of a<strong> cross-reactive allergic response.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Benzocaine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect</strong>, as it is an ester local anesthetic like procaine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Chloroprocaine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect, </strong>another ester local anesthetic.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Cocaine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect</strong>, also an ester local anesthetic and has additional significant side effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients <strong>allergic to ester local anesthetics</strong>, <strong>amide local anesthetics </strong>lik<strong>e mepivacaine </strong>are preferred due to their different<strong> metabolic pathways</strong>, <strong>reducing </strong>the risk of <strong>allergic reactions.</strong></span></span></span></p>",
      "correct_choice_id": 67555,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16895,
      "choices": [
        {
          "id": 67540,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malignant neuroleptic syndrome</span></span></span></p>"
        },
        {
          "id": 67541,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malignant hypertension</span></span></span></p>"
        },
        {
          "id": 67542,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malignant hyperthermia</span></span></span></p>"
        },
        {
          "id": 67543,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Upper motor neuron disorders</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dantrolene is useful in all except?</span></span></span></p>",
      "unique_key": "Q2417672",
      "question_audio": null,
      "question_video": null,
      "map_id": 36258,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Malignant hypertension</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dantrolene</strong> acts by<strong> inhibiting the release of calcium </strong>from the<strong> sarcoplasmic reticulum </strong>of skeletal muscle cells, effectively reducing <strong>muscle contraction. </strong>This mechanism is useful in treating conditions like <strong>malignant hyperthermia and neuroleptic malignant syndrome</strong>, where <strong>muscle rigidity and elevated body temperature </strong>are <strong>life-threatening</strong>. It is also used in managing<strong> spasticity in upper motor neuron disorders</strong>. However, it<strong> does not </strong>play a role in the treatment of <strong>malignant hypertension, </strong>which is a <strong>cardiovascular condition</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Malignant neuroleptic syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Correct, Dantrolene </strong>is used for the treatment of this syndrome, which can cause <strong>severe muscle rigidity and elevated temperature </strong>similar to<strong> malignant hyperthermia</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Malignant hyperthermia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Correct, </strong>it is a <strong>primary treatment </strong>for this condition, which involves a critical rise in<strong> body temperature and severe muscle contractions.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Upper motor neuron disorders:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Correct</strong>, <strong>Dantrolene helps </strong>manage symptoms of spasticity associated with these disorders.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dantrolene </strong>is valuable in conditions associated with <strong>hyperactivity of skeletal muscle contraction </strong>but<strong> not </strong>in the treatment of <strong>malignant hypertension, </strong>underscoring the importance of understanding its <strong>specific applications </strong>related to <strong>muscle relaxation and thermal regulation.</strong></span></span></span></p>",
      "correct_choice_id": 67541,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16884,
      "choices": [
        {
          "id": 67496,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epinephrine causes increased blood loss during delicate surgery</span></span></span></p>"
        },
        {
          "id": 67497,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epinephrine causes swelling of the tissues, making surgery more challenging</span></span></span></p>"
        },
        {
          "id": 67498,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epinephrine is contraindicated in emergency surgery</span></span></span></p>"
        },
        {
          "id": 67499,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epinephrine causes vasoconstriction, which can lead to vascular ischemia in digits</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 34-year-old carpenter presents to the ER after an accident in which he inadvertently chopped off the tip of his index finger. He is taken to the OR for reattachment of the digit, and after sedation, a local anesthetic is administered around the site of the injury. The local anesthetic used in the procedure did not contain any epinephrine, as it usually does for most surgical procedures. The reason for this is?</span></span></span></p>",
      "unique_key": "Q9388446",
      "question_audio": null,
      "question_video": null,
      "map_id": 36250,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Epinephrine causes vasoconstriction, which can lead to vascular ischemia in digits</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In<strong> surgeries involving </strong>areas with<strong> end arteries such as digits, </strong>the use of <strong>epinephrine is avoided </strong>due to its <strong>vasoconstrictive effects</strong>. Although <strong>epinephrine prolongs </strong>the <strong>anesthetic effect </strong>and <strong>reduces bleeding </strong>elsewhere,<strong> in digits </strong>it can <strong>severely reduce blood flow</strong>, risking<strong> tissue ischemia </strong>and <strong>potential loss of the digit.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options A and B.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect </strong>because <strong>epinephrine </strong>actually<strong> reduces blood loss </strong>and<strong> swelling </strong>in most<strong> surgical areas due to its vasoconstrictive effects.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect as epinephrine </strong>is not universally contraindicated in emergency surgeries, <strong>but its use depends on the specific circumstances and locations involved.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recognize the <strong>contraindication of epinephrine </strong>in local anesthetics used for surgeries<strong> on digits due to the risk of causing vascular ischemia</strong>,<strong> highlighting </strong>the need for careful consideration of <strong>vasoconstrictive additives </strong>in anesthetics<strong> depending on the surgical site</strong>.</span></span></p>",
      "correct_choice_id": 67499,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16885,
      "choices": [
        {
          "id": 67500,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chlorzoxazone</span></span></span></p>"
        },
        {
          "id": 67501,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Baclofen</span></span></span></p>"
        },
        {
          "id": 67502,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tizanidine</span></span></span></p>"
        },
        {
          "id": 67503,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pirenzepine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Centrally acting muscle relaxant with alpha 2 adrenergic agonist activity is:</span></span></span></p>",
      "unique_key": "Q6223479",
      "question_audio": null,
      "question_video": null,
      "map_id": 36251,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Tizanidine </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tizanidine </strong>is an<strong> alpha-2 adrenergic agonist </strong>that acts <strong>centrally to decrease spasticity</strong>. It works by<strong> inhibiting the release of excitatory neurotransmitters </strong>in the spinal cord, which helps in the management of <strong>spasticity </strong>associated with <strong>multiple sclerosis, spinal cord injury</strong>, and other <strong>neurological conditions. </strong>This mechanism of action<strong> specifically targets </strong>the pathways in the <strong>central nervous system </strong>responsible for <strong>muscle tone and reflexes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Chlorzoxazone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Acts primarily by <strong>depressing reflexes </strong>at the<strong> spinal level </strong>or possibly <strong>within the brain</strong>, but its exact <strong>mechanism is not well understood </strong>and does not involve alpha-2 adrenergic agonism.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Baclofen:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is a<strong> GABA-B receptor agonist </strong>that reduces <strong>excitatory transmission in the spinal cord, </strong>differing from the alpha-2 adrenergic mechanism of Tizanidine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pirenzepine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is an<strong> M1 muscarinic receptor antagonist </strong>primarily used to treat <strong>peptic ulcer disease</strong>, <strong>not </strong>related to<strong> muscle relaxation </strong>or <strong>alpha-2 adrenergic agonism.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Tizanidine&#39;s </strong>mechanism as <strong>an alpha-2 adrenergic agonist centrally </strong>reduces <strong>spasticity</strong>, distinguishing it from <strong>other muscle relaxants </strong>that may act through different <strong>neurotransmitter pathways or receptor types</strong>.</span></span></span></p>",
      "correct_choice_id": 67502,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16886,
      "choices": [
        {
          "id": 67504,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pseudocholinesterase deficiency</span></span></span></p>"
        },
        {
          "id": 67505,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phase II blockade</span></span></span></p>"
        },
        {
          "id": 67506,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle weakness due to repeated fasciculations</span></span></span></p>"
        },
        {
          "id": 67507,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Undiagnosed muscular dystrophy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70 kg young athlete was planned for surgery. during anaesthesia, vecuronium was not available, so repeated doses of succinylcholine was given intermittently up to 640 mg. During recovery, patient was not able to spontaneously respire and move limbs. What is the cause? </span></span></span></p>",
      "unique_key": "Q6618471",
      "question_audio": null,
      "question_video": null,
      "map_id": 36252,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Phase II blockade</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phase II blockade </strong>occurs with <strong>repeated or prolonged exposure to succinylcholine, </strong>a <strong>depolarizing neuromuscular blocking </strong>agent (NMB). Initially, <strong>succinylcholine </strong>causes continuous <strong>depolarization of the muscle membrane (phase I block), </strong>but with continued administration, it can <strong>transition to a phase II block</strong>, characterized by the <strong>nicotinic receptors </strong>becoming<strong> desensitized and the muscle membrane repolarizing </strong>yet becoming<strong> unresponsive to further stimulation. </strong>This change <strong>mimics </strong>the action of <strong>non-depolarizing blockers</strong>, leading to sustained <strong>muscle paralysis and inability to initiate muscle contractions</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Pseudocholinesterase deficiency:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Typically results in <strong>prolonged paralysis </strong>after the <strong>administration of succinylcholine </strong>due to <strong>decreased enzyme activity </strong>needed for its<strong> breakdown</strong>, but not directly linked to repeated doses.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Muscle weakness due to repeated fasciculations:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>initial fasciculations</strong> occur with <strong>succinylcholine,</strong> they <strong>do not </strong>usually result in <strong>long-term muscle weakness or inability to breathe.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Undiagnosed muscular dystrophy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Would <strong>not </strong>likely be revealed by the <strong>use of succinylcholine, </strong>and <strong>muscle weakness </strong>would have<strong> pre-existed the surgery.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></u></strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></u></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Repeated doses of succinylcholine </strong>can lead to a <strong>phase II blockade</strong>, a state where muscles become<strong> unresponsive to further neural stimulation </strong>despite being<strong> repolarized</strong>, important to <strong>monitor and manage </strong>during surgeries requiring<strong> prolonged muscle relaxation.</strong></span></span></span></p>",
      "correct_choice_id": 67505,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16893,
      "choices": [
        {
          "id": 67532,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreasing nerve conduction</span></span></span></p>"
        },
        {
          "id": 67533,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibiting spinal polysynaptic reflexes</span></span></span></p>"
        },
        {
          "id": 67534,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blocking conduction across NM junction</span></span></span></p>"
        },
        {
          "id": 67535,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acting as a GABA_A receptor agonist</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old office worker consults his family physician due to recurring neck and shoulder muscle spasms that have been troubling him for the last month. He mentions that these spasms seem to worsen after long hours of working at his computer. Physical examination shows localized muscle tenderness but no neurological abnormalities. After discussing treatment options and considering the patient&#39;s work environment, the physician thinks of prescribing cyclobenzaprine, a commonly used muscle relaxant, to alleviate the patient&#39;s symptoms.&nbsp;What is the primary mechanism of action of cyclobenzaprine in the treatment of muscle spasms?</span></span></span></p>",
      "unique_key": "Q3394971",
      "question_audio": null,
      "question_video": null,
      "map_id": 36256,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Inhibiting spinal polysynaptic reflexes</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cyclobenzaprine </strong>primarily acts <strong>at the level of the spinal cord </strong>and the <strong>brain stem</strong>, specifically targeting the<strong> polysynaptic reflex pathways </strong>that are responsible for <strong>initiating and maintaining muscle spasms</strong>. By <strong>dampening these reflexes, cyclobenzaprine</strong> effectively<strong> reduces muscle spasticity without</strong> directly interfering with <strong>muscle function or motor nerve fibers,</strong> making it ideal for <strong>symptomatic relief </strong>in conditions like those described by the patient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Decreasing nerve conduction:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect, </strong>as <strong>cyclobenzaprine </strong>does<strong> not </strong>primarily work by <strong>decreasing overall nerve conduction</strong>; it specifically<strong> targets polysynaptic reflexes</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Blocking conduction across NM junction:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect, </strong>this is characteristic of<strong> neuromuscular blocking agents </strong>used in<strong> anesthesia</strong>, not cyclobenzaprine.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Acting as a GABA_A receptor agonist:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect, cyclobenzaprine</strong> does not act via GABAergic mechanisms but through a <strong>modulation of serotoninergic and noradrenergic pathways</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cyclobenzaprine </strong>is effective in treating <strong>muscle spasms </strong>due to<strong> its ability to inhibit spinal polysynaptic reflexes</strong>, providing <strong>symptomatic relief </strong>from<strong> muscle rigidity and spasms </strong>commonly exacerbated by <strong>posture and repetitive motion</strong>. </span></span></span></p>",
      "correct_choice_id": 67533,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16890,
      "choices": [
        {
          "id": 67520,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Greater potential to block a resting nerve as compared to a stimulated nerve</span></span></span></p>"
        },
        {
          "id": 67521,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Need to cross the cell membrane to produce the block</span></span></span></p>"
        },
        {
          "id": 67522,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Large and myelinated fibers are blocked before the unmyelinated fibers</span></span></span></p>"
        },
        {
          "id": 67523,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cause consistent change of resting membrane potential</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blockade of nerve conduction by a local anesthetic is characterized by?</span></span></span></p>",
      "unique_key": "Q6496238",
      "question_audio": null,
      "question_video": null,
      "map_id": 36254,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Need to cross the cell membrane to produce the block</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Local anesthetics </strong>work by <strong>reversibly blocking nerve conduction</strong> through the <strong>inhibition of sodium channels </strong>on the <strong>neuron&#39;s cell membrane</strong>. To do this effectively, the <strong>local anesthetic </strong>must cross the <strong>neuronal cell membrane </strong>to reach these channels. Typically, local anesthetics are<strong> weak bases and exist in both ionized and unionized forms</strong>, allowing them to <strong>diffuse across the cell membrane</strong> in their <strong>unionized form.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Greater potential to block a resting nerve as compared to a stimulated nerve:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect, </strong>as local anesthetics more effectively<strong> block nerves </strong>that are frequently <strong>active or depolarized.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Large and myelinated fibers are blocked before the unmyelinated fibers:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect.&nbsp;</strong></span></span>In general, <strong>local anesthetics block smaller</strong>,<strong> unmyelinated fibers </strong>before</span><span style=\"font-size:14px\"><strong> larger, myelinated fibers. </strong></span><span style=\"font-size:16px\">This is because <strong>smaller fibers have a higher surface area </strong>to volume ratio and require less anesthetic to achieve <strong>effective blockade</strong>. <strong>Pain fibers (which are small and often unmyelinated) </strong>are typically <strong>blocked before motor fibers (which are larger and myelinated).</strong></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cause consistent change of resting membrane potential:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect, </strong>local anesthetics<strong> do not </strong>typically change the <strong>resting membrane potential</strong>; they block the action potential propagation by <strong>inhibiting sodium influx</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Local anesthetics </strong>must penetrate the<strong> neuronal membrane </strong>to effectively <strong>block nerve conduction, </strong>highlighting the importance of their<strong> lipophilic </strong>characteristics to <strong>cross membranes </strong>and achieve their<strong> pharmacological effect</strong>.</span></span></span></p>",
      "correct_choice_id": 67521,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16897,
      "choices": [
        {
          "id": 67548,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreases voluntary power and does not paralyze</span></span></span></p>"
        },
        {
          "id": 67549,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increases voluntary power and does not paralyze</span></span></span></p>"
        },
        {
          "id": 67550,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease muscle tone without reducing voluntary power</span></span></span></p>"
        },
        {
          "id": 67551,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreases voluntary power and cause muscle paralysis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism of action of centrally acting muscle relaxant:</span></span></span></p>",
      "unique_key": "Q2527525",
      "question_audio": null,
      "question_video": null,
      "map_id": 36244,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Decrease muscle tone without reducing voluntary power</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option C:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Centrally acting muscle relaxants </strong>reduce<strong> muscle tone </strong>primarily by acting on the<strong> central nervous system </strong>rather than directly on the muscles themselves. They <strong>decrease muscle spasticity and rigidity without </strong>affecting <strong>voluntary muscle power</strong>. These drugs modulate <strong>overactive reflexes </strong>and<strong> decrease</strong> the <strong>tone of skeletal muscles</strong>, making them effective in treating conditions like <strong>spasticity in multiple sclerosis</strong>, <strong>spinal cord injuries, or other neurological disorders.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Decreases voluntary power and does not paralyze:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect, </strong>as these drugs<strong> do not </strong>typically <strong>decrease voluntary power.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Increases voluntary power and does not paralyze:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect,</strong> these drugs <strong>do not increase voluntary power</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Decreases voluntary power and cause muscle paralysis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect,</strong> centrally acting muscle relaxants <strong>do not cause paralysis or decrease voluntary power.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Centrally acting muscle relaxants </strong>are effective in managing <strong>spasticity by decreasing muscle tone </strong>without compromising <strong>voluntary muscle control</strong>,<strong> ideal for patients </strong>with<strong> chronic spastic conditions.</strong></span></span></span></p>",
      "correct_choice_id": 67550,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16894,
      "choices": [
        {
          "id": 67536,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Slow induction and recovery</span></span></span></p>"
        },
        {
          "id": 67537,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-explosive</span></span></span></p>"
        },
        {
          "id": 67538,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Minimal cardiovascular side-effects</span></span></span></p>"
        },
        {
          "id": 67539,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low blood solubility</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Regarding Xenon anesthesia all are true except?</span></span></span></p>",
      "unique_key": "Q8867893",
      "question_audio": null,
      "question_video": null,
      "map_id": 36257,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Slow induction and recovery</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Xenon is a noble gas </strong>used as an <strong>anesthetic agent </strong>with several <strong>beneficial properties</strong>, including<strong> low blood solubility </strong>which allows for <strong>rapid induction and recovery</strong>&mdash;<strong>not slow</strong> as mentioned in <strong>option A.</strong> Its<strong> minimal impact on cardiovascular function </strong>and <strong>non-explosive </strong>nature make it a<strong> very safe but expensive </strong>choice in clinical settings.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Non-explosive:</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Correct, Xenon is non-explosive, </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">which contributes to its </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">safety profile in anesthetic applications.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Minimal cardiovascular side-effects:</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Correct, </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">it has</span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> minimal effects on the cardiovascular system,</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> making it suitable for</span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> patients with cardiovascular instability.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Low blood solubility:</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Correct, the low solubility facilitates </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">quick onset and offset of its anesthetic effects</span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, leading to rapid recovery.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Xenon </strong>is Greek for<strong> stranger. </strong>It is the only noble gas to be <strong>anaesthetic under normobaric conditions</strong>. Xenon is <strong>extremely rare </strong>with an <strong>average room </strong>containing only <strong>4 ml</strong>. It is very close to the &lsquo;<strong>ideal agent&rsquo;.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Advantages of Xenon Anesthesia</span></strong></span></span></p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inert (probably non-toxic to liver and kidney with no metabolism)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Minimal effect on CVS function</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lowest blood solubility (Lowest blood gas partition coefficient) therefore rapid induction and recovery.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Does not trigger malignant hyperthermia</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Environment friendly</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Non-explosive</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disadvantages of Xenon Anesthesia</span></strong></span></span></p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">High cost</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low potency (MAC = 70%)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">No commercially available anaesthesia equipment.</span></span></span></li>\r\n</ol>",
      "correct_choice_id": 67536,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16896,
      "choices": [
        {
          "id": 67544,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Persistently depolarizing at neuromuscular junction</span></span></span></p>"
        },
        {
          "id": 67545,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Act competitively on Ach receptors blocking post-synaptically</span></span></span></p>"
        },
        {
          "id": 67546,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Repetitive stimulation of Ach receptors on muscle end plate</span></span></span></p>"
        },
        {
          "id": 67547,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibiting the calcium channel on presynaptic membrane</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism of action of curare like drugs are:</span></span></span></p>",
      "unique_key": "Q3516439",
      "question_audio": null,
      "question_video": null,
      "map_id": 36243,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Act competitively on Ach receptors blocking post-synaptically</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Curare-like </strong>drugs, also known as <strong>non-depolarizing neuromuscular blocking agents</strong>, function by <strong>competitively blocking </strong>the <strong>acetylcholine receptors </strong>at the<strong> neuromuscular junction</strong>. By competing with acetylcholine for binding to these receptors, they<strong> prevent </strong>the<strong> initiation of muscle contraction</strong>, leading to <strong>muscle relaxation and paralysis, </strong>which is useful during surgical procedures to maintain muscle relaxation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Persistently depolarizing at neuromuscular junction:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect</strong>, this describes the mechanism of depolarizing blockers like succinylcholine, not curare-like drugs.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Repetitive stimulation of Ach receptors on muscle end plate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect</strong>, <strong>curare-like </strong>drugs<strong> block </strong>rather than stimulate these receptors.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Inhibiting the calcium channel on presynaptic membrane:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect, </strong>curare-like drugs do not interact with calcium channels in their primary mechanism of action.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><em><strong>Curare-like drugs </strong>are<strong> non-depolarizing neuromuscular blockers </strong>that work by <strong>competing with acetylcholine </strong>at the <strong>neuromuscular junction,</strong> effectively <strong>preventing muscle contractions </strong>necessary for various<strong> surgical procedures</strong>.</em></p>",
      "correct_choice_id": 67545,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16901,
      "choices": [
        {
          "id": 67564,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atracurium</span></span></p>"
        },
        {
          "id": 67565,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Baclofen</span></span></p>"
        },
        {
          "id": 67566,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Halothane</span></span></p>"
        },
        {
          "id": 67567,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Succinylcholine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">While rescuing a child from a burning home, a firefighter was burned over 60% of his body. He is rushed to the emergency room and quickly taken into surgery. During the surgery, the anesthesiologist notices tall, peaked T waves and prolongation of the PR interval, accompanied by progressive widening of the QRS complex so that it appears to merge with the T waves. The patient goes into ventricular fibrillation, then asystole, and cannot be resuscitated. Which of the following agents is most likely responsible for this patient&#39;s electrocardiographic changes?</span></span></span></p>",
      "unique_key": "Q4549220",
      "question_audio": null,
      "question_video": null,
      "map_id": 36248,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Succinylcholine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Succinylcholine</strong>, a <strong>depolarizing neuromuscular blocking agent </strong>commonly used in <strong>rapid sequence induction and tracheal intubation</strong>, is known to cause a <strong>transient increase </strong>in<strong> serum potassium levels. T</strong>his effect is particularly pronounced in patients with extensive <strong>soft tissue damage,</strong> such as <strong>burn victims</strong>, where it can lead to <strong>severe hyperkalemia</strong>. The <strong>firefighter&rsquo;s </strong>significant <strong>burn injuries </strong>would exacerbate the <strong>hyperkalemic response to Succinylcholine, </strong>resulting in the <strong>electrocardiographic abnormalities observed</strong>&mdash;<strong>tall peaked T waves, PR interval prolongation, and widened QRS complex merging with T waves</strong>, leading to<strong> ventricular fibrillation and asystole</strong>.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Atracurium:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect,</strong> as it is a<strong> non-depolarizing neuromuscular blocker </strong>that <strong>does not </strong>significantly affect <strong>serum</strong> <strong>potassium levels.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Baclofen:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Incorrect</strong>, it is a <strong>centrally acting muscle relaxant </strong>used for <strong>spasticity</strong> and<strong> does not </strong>cause <strong>electrolyte imbalances.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Halothane:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Incorrect</strong>, it is known for potential risks of <strong>hepatotoxicity and malignant hyperthermia </strong>but<strong> does not</strong> typically induce <strong>hyperkalemia.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with<strong> extensive burns, succinylcholine </strong>should be <strong>avoided </strong>due to the <strong>risk of exacerbating hyperkalemia,</strong> which can lead to <strong>life-threatening cardiac arrhythmias and cardiac arrest.</strong></span></span></span></span></span></p>",
      "correct_choice_id": 67567,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16900,
      "choices": [
        {
          "id": 67560,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketamine</span></span></p>"
        },
        {
          "id": 67561,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enflurane</span></span></p>"
        },
        {
          "id": 67562,
          "text": "<p><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propofol</span></span></p>"
        },
        {
          "id": 67563,
          "text": "<p style=\"margin-right:38px; text-align:justify\"><span dir=\"ltr\" lang=\"IT\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Remifentanil</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Postoperative vomiting is uncommon with this intravenous anaesthetic agent and patient are able to ambulate sooner than those who receive other anaesthetic agents:</span></span></span></p>",
      "unique_key": "Q5789767",
      "question_audio": null,
      "question_video": null,
      "map_id": 36247,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Propofol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propofol </strong>is recognized for its<strong> favorable postoperative profile </strong>due to its <strong>unique pharmacokinetic properties</strong>. It is an <strong>intravenous anaesthetic agent </strong>that offers several advantages, including a <strong>lower incidence of postoperative nausea and vomiting (PONV</strong>) compared to many other anesthetics. This is crucial as PONV can significantly affect<strong> patient comfort and recovery time</strong>. Additionally, <strong>Propofol facilitates</strong> quicker recovery times, enabling patients to <strong>regain consciousness </strong>and mobility sooner than with other agents. Its <strong>rapid onset </strong>and <strong>offset of action allow for a smoother transition </strong>out of anesthesia, which helps in <strong>reducing the duration of postoperative disorientation and immobility</strong>. These qualities make<strong> Propofol </strong>particularly<strong> suitable for outpatient </strong>or <strong>day surgeries </strong>where <strong>rapid recovery and early discharge are desirable.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Ketamine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Known for causing<strong> postoperative hallucinations and emergence reactions</strong>, which can <strong>delay recovery.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Enflurane:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> An <strong>older inhalation </strong>anesthetic associated with <strong>longer recovery times and higher incidences of PONV.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Remifentanil:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While effective for <strong>pain management</strong>, it is an <strong>opioid and does not</strong> inherently <strong>reduce PONV </strong>or<strong> quicken recovery times </strong>compared to Propofol.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propofol </strong>is advantageous for its <strong>antiemetic properties </strong>and its ability to allow patients to <strong>ambulate sooner after surgery</strong>, which supports its <strong>preference in settings </strong>that require <strong>rapid recovery and minimal postoperative complications</strong>. This makes it the <strong>agent of choice for day surgeries </strong>and procedures requiring <strong>short recovery times</strong>.</span></span></span></span></span></span></p>",
      "correct_choice_id": 67562,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}